🇺🇸 FDA
Pipeline program

TAMOXIFEN, LETROZOLE, ANASTROZOLE, FULVESTRANT, LEUPRORELIN, OXYBUTYNIN, GOSERELIN, VENLAFAXINE, LEUPRORELIN, GOSERELIN, EXEMESTANE, VENLAFAXINE

Phase 3 small_molecule active

Quick answer

TAMOXIFEN, LETROZOLE, ANASTROZOLE, FULVESTRANT, LEUPRORELIN, OXYBUTYNIN, GOSERELIN, VENLAFAXINE, LEUPRORELIN, GOSERELIN, EXEMESTANE, VENLAFAXINE for Breast cancer is a Phase 3 program (small_molecule) at Rein Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Rein Therapeutics
Indication
Breast cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials